Adding Insulin to IVF Culture Media Significantly Improve Outcome

Sponsor
Ibn Sina Hospital (Other)
Overall Status
Completed
CT.gov ID
NCT02420171
Collaborator
Banon IVF Center Assiut, Egypt (Other)
360
2
2
11
180
16.4

Study Details

Study Description

Brief Summary

Add insulin to a single step culture media for IVF embryo culture from day 0 to day 5/6 of In Vitro culture and detect the the effect upon embryo quality and implantation potential.

Condition or Disease Intervention/Treatment Phase
  • Other: Adding insulin to In Vitro culture media
N/A

Detailed Description

The IVF culture media design and upgrade underwent many ideas during the last 3 decades, we suppose that adding insulin as a hormon and growth factor might improve embryo development in vitro so we decide to design a trial to compare the embryogenesis by sibling Oocytes of the same patient between to arm of the same culture media and yhe same culture condition but with one arm with insulin and the other is traditional one and closely monitor the outcome within the 2 arms abd record the results

Study Design

Study Type:
Interventional
Actual Enrollment :
360 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Basic Science
Study Start Date :
Jan 1, 2015
Actual Primary Completion Date :
Dec 1, 2015
Actual Study Completion Date :
Dec 1, 2015

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: In Vitro culture media with insulin

We will add insulin to the single step culture media to monitor the embryogenesis

Other: Adding insulin to In Vitro culture media
We will add insulin for in vitro culture of human embryos

No Intervention: In Vitro culture media without insulin m

The embryos will be cultured in the media without insulin and compare this arm as the control arm with the interventional one.

Outcome Measures

Primary Outcome Measures

  1. clinical Pregnancy rate ( % ) [6 months]

Secondary Outcome Measures

  1. Blastocyst rate ( % ) [6 months]

  2. Blastocyst quality rate ( % ) [6 months]

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 40 Years
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • normal responder

  • PCOS

  • Tubal factor infertility

  • mild asthenozoospermia

Exclusion Criteria:
  • patient over 40

Contacts and Locations

Locations

Site City State Country Postal Code
1 Banon IVF Center Assiut Egypt
2 Ibnsina IVF center Sohag Egypt

Sponsors and Collaborators

  • Ibn Sina Hospital
  • Banon IVF Center Assiut, Egypt

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Muhammad Fawzy, IVF Laboratory Director, Ibn Sina Hospital
ClinicalTrials.gov Identifier:
NCT02420171
Other Study ID Numbers:
  • Ibnsina IVF center Sohag
First Posted:
Apr 17, 2015
Last Update Posted:
Jul 13, 2016
Last Verified:
Jul 1, 2016
Keywords provided by Muhammad Fawzy, IVF Laboratory Director, Ibn Sina Hospital
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jul 13, 2016